Atherosclerotic vascular disease rather than metabolic syndrome predicts ischemic stroke in diabetic patients

Cerebrovascular Diseases

Volumn 30, Issue 4, 2010, Pages 374-379

  Chen, Xiang Yan ^a   Thomas, G Neil ^b   Chen, Yang Kun ^a   Chan, Juliana C N ^a   Wong, Ka Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atherosclerosis; Diabetes; Ischemic stroke; Metabolic syndrome

Indexed keywords

GLUCOSE; LIPID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ASIAN; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD PRESSURE; BODY MASS; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CHINESE; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; GLYCEMIC INDEX; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE CEREBRAL ARTERY OCCLUSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; AGED; ATHEROSCLEROSIS; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77955198340     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319570     Document Type: Article

References (29)

1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787.
2. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
3. Cheung BM, Thomas GN: The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets 2007;7:79-85.
4. Wang JJ, Li HB, Kinnunen L, Hu G, Jarvinen TM, Miettinen ME, Yuan S, Tuomilehto J: How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 2007;192:161-168.
5. Ozaki R, Qiao Q, Wong GW, Chan MH, So WY, Tong PC, Ho CS, Ko GT, Kong AP, Lam CW, Tuomilehto J, Chan JC: Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents. Arch Dis Child 2007;92:224-228.
6. Ko GT, Cockram CS, Chow CC, Yeung V, Chan WB, So WY, Chan NN, Chan JC: High prevalence of metabolic syndrome in Hong Kong Chinese: comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005;69:160-168.
7. Thomas GN, Chen XY, Lin JW, Tomlinson B, Lam WW, Liu R, Yeung VT, Chan JC, Wong KS: Middle cerebral artery stenosis increased the risk of vascular disease mortality among type 2 diabetic patients. Cerebrovasc Dis 2008;25:261-267.
8. Thomas GN, Tomlinson B, Chan JC, Sanderson JE, Cockram CS, Critchley JA: Reninangiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care 2001;24:356-361.
9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
10. Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J 1993;69:204-210.
11. Thomas GN, Critchley JA, Tomlinson B, Lee ZS, Young RP, Cockran CS, Chan JC: Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese. Clin Nephrol 2001;55:7-15.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
14. Hong Kong Government Department of Health: Government Mortality Statistics 2005. http://www.info.gov. hk/dh/disease/(last accessed November 23, 2005).
15. Holscher T, Schlachetzki F, Zimmermann M, Jakob W, Ittner KP, Haslberger J, Bogdahn U, Boy S: Transcranial ultrasound from diagnosis to early stroke treatment. 1. Feasibility of prehospital cerebrovascular assessment. Cerebrovasc Dis 2008;26:659-663.
16. Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, Kay R: Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000;31:2641-2647.
17. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778.
18. Galassi A, Reynolds K, He J: Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-819.
19. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007;49:403-414.
20. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS: The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007;30:1206-1211.
21. Koren-Morag N, Goldbourt U, Tanne D: Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 2005;36:1366-1371.
22. Bang OY, Kim JW, Lee JH, Lee MA, Lee PH, Joo IS, Huh K: Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005;65:296-298.
23. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB, Wolf PA: Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006;166:106-111.
24. Li W, Ma D, Liu M, Liu H, Feng S, Hao Z, Wu B, Zhang S: Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovasc Dis 2008;25:539-547.
25. Thomas GN, Lin JW, Lam WW, Tomlinson B, Yeung V, Chan JC, Wong KS: Middle cerebral artery stenosis in type II diabetic Chinese patients is associated with conventional risk factors but not with polymorphisms of the renin-angiotensin system genes. Cerebrovasc Dis 2003;16:217-223.
26. Huang YN, Gao S, Li SW, Huang Y, Li JF, Wong KS, Kay R: Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997;48:524-525.
27. Wilson PW, McGee DL, Kannel WB: Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am J Epidemiol 1981;114:697-704.
28. Wilson PW, Anderson KM, Kannel WB: Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am J Med 1986;80:3-9.
29. Haffner SM: Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol 2003;92:18J-26J.